28 results
8-K
EX-99.1
CRBP
Corbus Pharmaceuticals Holdings Inc
5 Feb 24
Regulation FD Disclosure
8:12am
efficacy of incretin analogs
LeadershipUpcoming catalysts Financials
Management Team Yuval Cohen, PhD Chief Executive Officer, Director Corbus co … ) Catlin Director More than 25 years of senior financial leadership experience in life science companies; Former CFO and Secretary of Celldex
8-K
EX-99.2
CRBP
Corbus Pharmaceuticals Holdings Inc
26 Jan 24
Regulation FD Disclosure
7:47am
Enhance efficacy of incretin analogs
LeadershipUpcoming catalysts Financials
Management Team Yuval Cohen, PhD Chief Executive Officer, Director Corbus … . (Chip) Catlin Director More than 25 years of senior financial leadership experience in life science companies; Former CFO and Secretary of Celldex
8-K
EX-99.1
thsts27cy7
14 Nov 23
Regulation FD Disclosure
5:19pm
8-K
EX-99.1
gcr93g89
3 Aug 23
Other Events
8:44am
8-K
8c92m
26 Sep 22
Corbus Pharmaceuticals Appoints Anne Altmeyer, PhD to Board of Directors
5:00pm
8-K
59e6ye jtn
28 Sep 21
Departure of Directors or Certain Officers
9:25am
8-K
EX-99.1
1fk5rkq 1r
6 Aug 20
Corbus Pharmaceuticals Reports Second Quarter Financial Results and Corporate Updates
7:35am
8-K
EX-99.1
dcrluj37l fra
8 Jul 20
Corbus Pharmaceuticals Appoints George Golumbeski, Ph.D., to Board of Directors
8:30am
8-K
1znt nhq59dq9k
10 Mar 20
Corbus Pharmaceuticals Announces Changes to its Board and Appointment of Pete Salzmann, M.D. as Independent Director
8:51am
8-K
EX-99.1
8dg w6w4e
10 Mar 20
Corbus Pharmaceuticals Announces Changes to its Board and Appointment of Pete Salzmann, M.D. as Independent Director
8:51am
8-K
EX-99.1
afn5yj 6c043i
8 Aug 19
Corbus Pharmaceuticals Reports 2019 Second Quarter Financial Results and Provides Clinical and Corporate Updates
7:30am